Concepedia

Fred Grossman

FG

Statistics

Publications

16

Citations

2.4K

H-Index

12

Active since

1993

Affiliations

Johnson & Johnson (United States)(Current)

Icahn School of Medicine at Mount Sinai

Eli Lilly (United States)

Tisch Hospital

Fred Grossman is an author at Johnson & Johnson (United States) specializing in psychopharmacology, psychiatry, and antipsychotic pharmacotherapy.

Publications per year

1993–2022

16

Publications

16

A Randomized Placebo-Controlled Trial of Risperidone for the Treatment of Aggression, Agitation, and Psychosis of Dementia

Henry Brodaty, David Ames, John Snowdon et al. · The Journal of Clinical Psychiatry · 2003 · 466 citations

, , +17

Combination of a Mood Stabilizer With Risperidone or Haloperidol for Treatment of Acute Mania: A Double-Blind, Placebo-Controlled Comparison of Efficacy and Safety

Fred Grossman, S. Nassir Ghaemi, Akiko Okamoto et al. · American Journal of Psychiatry · 2002 · 426 citations

, , +17

Rapid Antimanic Effect of Risperidone Monotherapy: A 3-Week Multicenter, Double-Blind, Placebo-Controlled Trial

Robert M. A. Hirschfeld, Paul E. Keck, Michelle Kramer et al. · American Journal of Psychiatry · 2004 · 273 citations

, , +17

Mood stabilisers plus risperidone or placebo in the treatment of acute mania

Fred Grossman, Ilse Augustyns, Eduard Vieta et al. · The British Journal of Psychiatry · 2003 · 248 citations · Full text

, , +16

GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis

Emma Guttman‐Yassky, Ana B. Pavel, Lisa Zhou et al. · Journal of Allergy and Clinical Immunology · 2019 · 222 citations · Full text

, , +17

1–5 of 16